Cardlytics: Amit Gupta proposes $18.7K share sale
The notice also lists five common-stock sales by Amit Gupta during the preceding three months.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cardlytics, Inc. (CDLX) officer and director Amit Gupta reported a proposed sale of 7,382 common shares, with an aggregate market value of $18,700.82 and an approximate sale date of October 2, 2026. The shares were reported as restricted stock vested October 1, 2026; the notice states that the sale includes an amount necessary to cover a tax obligation resulting from settlement of a vested equity award.
Key Figures
Key Terms
Rule 144 regulatory
Restricted Stock Vesting financial
vested equity award distribution financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.